Cite
MLA Citation
S. Van Hees et al.. “Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes.” Alimentary pharmacology & therapeutics, vol. 47, no. 8, 2018, pp. 1170–1180. http://access.bl.uk/ark:/81055/vdc_100058077576.0x00004b